Marcus E. Kleber

52.9k total citations
192 papers, 4.8k citations indexed

About

Marcus E. Kleber is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Marcus E. Kleber has authored 192 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Cardiology and Cardiovascular Medicine, 53 papers in Surgery and 40 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Marcus E. Kleber's work include Lipoproteins and Cardiovascular Health (37 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (27 papers) and Blood Pressure and Hypertension Studies (21 papers). Marcus E. Kleber is often cited by papers focused on Lipoproteins and Cardiovascular Health (37 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (27 papers) and Blood Pressure and Hypertension Studies (21 papers). Marcus E. Kleber collaborates with scholars based in Germany, Austria and United States. Marcus E. Kleber's co-authors include Winfried März, Tanja B. Grammer, Hubert Scharnagl, Günther Silbernagel, Stefan Pilz, Graciela E. Delgado, Bernhard K. Krämer, Stefan Lorkowski, Graciela Delgado and Bernhard O. Boehm and has published in prestigious journals such as Circulation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Marcus E. Kleber

177 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcus E. Kleber Germany	37	1.2k	1.1k	998	751	588	192	4.8k
Mahmut İlker Yılmaz Türkiye	48	1.4k 1.2×	968 0.9×	921 0.9×	959 1.3×	954 1.6×	151	6.3k
Zuyi Yuan China	37	1.4k 1.2×	968 0.9×	1.7k 1.7×	557 0.7×	548 0.9×	240	5.3k
Dylan Burger Canada	36	1.3k 1.1×	574 0.5×	2.3k 2.3×	590 0.8×	715 1.2×	125	5.4k
Pablo E. Pérgola United States	44	1.7k 1.4×	706 0.7×	1.5k 1.5×	801 1.1×	1.2k 2.1×	135	7.1k
Lorenzo A. Calò Italy	34	890 0.8×	515 0.5×	1.5k 1.5×	875 1.2×	714 1.2×	234	4.2k
Felipe Javier Chaves Spain	36	631 0.5×	641 0.6×	1.3k 1.3×	706 0.9×	757 1.3×	205	4.6k
Jane Armitage United Kingdom	31	1.2k 1.0×	2.6k 2.4×	807 0.8×	1.2k 1.6×	452 0.8×	92	5.7k
Neeraj Dhaun United Kingdom	34	1.4k 1.2×	473 0.4×	909 0.9×	494 0.7×	1.0k 1.7×	147	4.8k
Toshiki Moriyama Japan	43	948 0.8×	738 0.7×	1.3k 1.3×	652 0.9×	556 0.9×	220	5.5k
Kristiina Nyyssönen Finland	45	1.0k 0.9×	1.3k 1.2×	1.3k 1.3×	1.5k 1.9×	701 1.2×	68	7.9k

Countries citing papers authored by Marcus E. Kleber

Since Specialization

Citations

This map shows the geographic impact of Marcus E. Kleber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus E. Kleber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus E. Kleber more than expected).

Fields of papers citing papers by Marcus E. Kleber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus E. Kleber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus E. Kleber. The network helps show where Marcus E. Kleber may publish in the future.

Co-authorship network of co-authors of Marcus E. Kleber

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus E. Kleber. A scholar is included among the top collaborators of Marcus E. Kleber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus E. Kleber. Marcus E. Kleber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kleber, Marcus E., Nicolas Meunier‐Beillard, Isabelle Fournel, et al.. (2025). Barriers to and facilitators of rehabilitation according to socio-economic status, after acute respiratory distress syndrome due to COVID-19: A qualitative study in the RECOVIDS cohort. PLoS ONE. 20(2). e0316318–e0316318.

Scharnagl, Hubert, et al.. (2025). Biomarker-based risk assessment of dietary intervention in patients with coronary artery disease during cardiac rehabilitation—a quasi-experimental study. Frontiers in Nutrition. 12. 1669931–1669931.

Dawczynski, Christine, Peter Schlattmann, Michael Kiehntopf, et al.. (2025). Reduction of cardiovascular risk factors by the diet – Evaluation of the MoKaRi concept by a parallel-designed randomized study. Lipids in Health and Disease. 24(1). 88–88. 1 indexed citations

Delgado, Graciela E., Hubert Scharnagl, R. Siekmeier, et al.. (2025). Comparing Inflammatory Biomarkers in Cardiovascular Disease: Insights from the LURIC Study. International Journal of Molecular Sciences. 26(15). 7335–7335. 1 indexed citations

Timofeeva, Maria, Cathy Wyse, Jos van Geffen, et al.. (2025). Genome-wide gene-environment interaction study uncovers 162 vitamin D status variants using a precise ambient UVB measure. Nature Communications. 16(1). 10774–10774.

Herrmann, Markus, Martin H. Keppel, Sieglinde Zelzer, et al.. (2024). The role of functional vitamin D deficiency and low vitamin D reservoirs in relation to cardiovascular health and mortality. Clinica Chimica Acta. 558. 118230–118230. 1 indexed citations

Kleber, Marcus E., Ksenija Stach, Faeq Husain‐Syed, et al.. (2024). Association between Arterial Stiffness, Carbamylation, and Mortality in Patients Undergoing Coronary Angiography with No or Mild Chronic Kidney Disease. Cardiorenal Medicine. 15(1). 83–97.

Kleber, Marcus E., Brigitte M. Winklhofer‐Roob, Wilfried Renner, et al.. (2024). Haptoglobin polymorphism, vitamin E and mortality: the Ludwigshafen Risk and Cardiovascular Health Study. BMJ Nutrition Prevention & Health. 7(2). 296–303.

Spira, Dominik, Priska Binner, Marcus E. Kleber, et al.. (2024). Clinical characterization and mutation spectrum of patients with hypertriglyceridemia in a German outpatient clinic. Journal of Lipid Research. 65(7). 100589–100589.

10.

Scharnagl, Hubert, Graciela E. Delgado, Bernhard K. Krämer, et al.. (2024). Clinical and genetic diagnosis of familial hypercholesterolaemia in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study. European Heart Journal - Quality of Care and Clinical Outcomes. 10(7). 632–640. 1 indexed citations

11.

Herrmann, Markus, Sieglinde Zelzer, Étienne Cavalier, et al.. (2023). Functional Assessment of Vitamin D Status by a Novel Metabolic Approach: The Low Vitamin D Profile Concept. Clinical Chemistry. 69(11). 1307–1316. 15 indexed citations

12.

Screever, Elles M., A. Rogier van der Velde, Herman H.W. Silljé, et al.. (2023). Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance. International Journal of Molecular Sciences. 24(5). 4415–4415. 2 indexed citations

13.

Delgado, Graciela E., Bernhard K. Krämer, Christine Dawczynski, et al.. (2022). Gender- and subgroup-specific sensitivity analysis of alcohol consumption and mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Data in Brief. 41. 107873–107873.

14.

Silbernagel, Günther, Hubert Scharnagl, Christoph H. Saely, et al.. (2022). The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs. Biomedicines. 10(6). 1302–1302. 9 indexed citations

15.

Pott, Janne, Jesper R. Gådin, Elizabeth Theusch, et al.. (2021). Meta-GWAS of PCSK9 levels detects two novel loci atAPOBandTM6SF2. Human Molecular Genetics. 31(6). 999–1011. 13 indexed citations

16.

Schiekofer, Stephan, Marcus E. Kleber, Winfried Maerz, Franz Maximilian Rasche, & Jochen G. Schneider. (2017). The Proline 7 Substitution in the Preproneuropeptide Y Is Associated with Higher Hepatic Lipase Activity In Vivo. International Journal of Endocrinology. 2017. 1–7. 5 indexed citations

17.

Kleber, Marcus E., Graciela E. Delgado, Stefan Lorkowski, Winfried März, & Clemens von Schacky. (2016). Omega-3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis. 252(2). 175–181. 85 indexed citations

18.

Koller, Lorenz, Marcus E. Kleber, Georg Goliasch, et al.. (2014). C-Reactive Protein Predicts Mortality in Patients Referred for Coronary Angiography and Symptoms of Heart Failure With Preserved Ejection Fraction. European Journal of Heart Failure. 16(7). 758–766. 54 indexed citations

19.

Hartaigh, Bríain ó, Jos A. Bosch, G. Neil Thomas, et al.. (2012). Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Atherosclerosis. 224(1). 161–169. 74 indexed citations

20.

Hartaigh, Bríain ó, Jos A. Bosch, Douglas Carroll, et al.. (2012). Evidence of a synergistic association between heart rate, inflammation, and cardiovascular mortality in patients undergoing coronary angiography. European Heart Journal. 34(12). 932–941. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact